Voloridge Investment Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-29,408
Closed -$819K 1591
2022
Q4
$819K Buy
+29,408
New +$779K ﹤0.01% 1176
2021
Q1
Sell
-77,131
Closed -$2.24M 1630
2020
Q4
$2.24M Sell
77,131
-689
-0.9% -$17.1K 0.02% 692
2020
Q3
$1.7M Buy
77,820
+64,721
+494% +$1.15M 0.01% 772
2020
Q2
$152K Buy
+13,099
New +$144K ﹤0.01% 1210

Other funds holding SGRY

Voloridge Investment Management's SGRY Position: Q1 2023 in Review

Voloridge Investment Management sold out of Surgery Partners (SGRY) in Q1 2023, closing a stake of 29,408 shares — an estimated $819K sold.

Voloridge Investment Management first reported a position in SGRY in Q2 2020 and held it in 4 quarters. The position peaked at $2.24M in Q4 2020. 151 funds tracked by Wall St. Rank hold SGRY as of Q1 2023.

  • Voloridge Investment Management reported no remaining Surgery Partners position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 29,408 Surgery Partners shares in Q1 2023, an estimated $819K.
  • Voloridge Investment Management first reported a position in Surgery Partners in Q2 2020 and held it in 4 quarters.
  • Voloridge Investment Management's Surgery Partners position peaked at $2.24M in Q4 2020.
  • 151 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.